Hair Loss Firm Veradermics Jumps 124% After $256 Million IPO
Shares of hair-restoration drug developer Veradermics Inc. more than doubled in the company’s trading debut after it raised $256.3 million in an initial public offering.
About The Author
Discover more from MEK Enterprises Blog - Breaking News, SEO, Information, and Making Money Online!
Subscribe to get the latest posts sent to your email.
